FDA Requires Lower Lunesta Starting Dose

The agency has announced it will be requiring a lower starting dose for the sleep drug

The FDA has announced it will be requiring the manufacturer of Lunesta (eszopiclone), a sleep drug, to lower the current recommended starting dose on the drug’s label. According to a report from the FDA, data has shown that eszopiclone levels in some patients may be high enough the morning after use that they could impair activities that require alertness. Patients may feel fully awake but actually be impaired.

The recommended dose has been lowered from 2 mg to 1 mg for both men and women. The drug’s dose can be increased to 2 or 3 mg, though a higher dose is more likely to result in next day impairment. The change in dose comes as a result of a recent study that followed 91 healthy adults ages 25-40. The study showed that Lunesta 3 mg, when compared to a placebo pill, was associated with “severe next-morning psychomotor and memory impairment in both men and women 7.5 hours after taking the drug.”

“To help ensure patient safety, health care professionals should prescribe, and patients should take, the lowest dose of a sleep medicine that effectively treats their insomnia,” said Ellis Unger, M.D., director, Office of Drug Evaluation I in the FDA's Center for Drug Evaluation and Research, in the FDA’s press release. “Recently, data from clinical trials and other types of studies have become available, which allowed the FDA to better characterize the risk of next-morning impairment with sleep drugs.”

Current Lunesta users taking 2 or 3 mg should consult their health care professional for next step instructions. 

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • Complete Online Safety Training Courses

    Deliver state-of-the art, online safety training courses to your organization with IndustrySafe Training Management Software. Generate reports to track training compliance and automatically notify learners of upcoming or overdue classes.

  • Easy to Use Safety Inspection App

    Conduct inspections on the go with IndustrySafe’s mobile app. Complete safety audits at job sites and remote locations—with or without web access.

  • Track Key Safety Performance Indicators

    IndustrySafe’s Dashboard Module allows organizations to easily track safety KPIs and metrics. Gain increased visibility into your business’ operations and safety data.

  • Analyze Incident Data and Maintain OSHA Compliance

    Collect relevant incident data, analyze trends, and generate accurate regulatory reports, including OSHA 300, 300A, and 301 logs, through IndustrySafe’s extensive incident reporting and investigation module.

  • Industry Safe
comments powered by Disqus